Wonisch Willibald
Graz, Styria, 8036, Austria
NCT Number: NCT03444155
In a cross-over study the investigators evaluate the effects of natural (Panmol-B-Complex) (Pan [Greek] = all; moles [Latin] = molecules/particles - brand name) versus synthetic vitamin B complexes to identify the bioavailability of distinct vitamins as well as long-term effects. The primary hypothesis for this study: "Natural Vitamin B-complexes are as effective as synthetic Vitamin B-complexes or better." For this reason 30 subjects (18 to 65y; BMI >19 to <29) were recruited for this study. The study population was divided into 2 groups of each 15 subjects in a cross-over trial. Vitamin supplementation consisted of Thiamine (2.93 mg), Riboflavin (3.98 mg), Niacin (29.85 mg), Pantothenic acid (10.95 mg), Pyridoxine (3.38 mg), Biotin (0.108 mg), Folic acid (0.69 mg) and Cobalamin (8.85 µg) per day in both groups. Blood samples are taken at baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - wash out phase I (2 weeks); start cross-over: baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - washout phase II (6 weeks). In case of main target criteria Thiamin, Riboflavin, Pyridoxine, Folic acid and Cobalamin were measured in serum as well as total peroxides (µmol/L), peroxidase-activity (U/L), total antioxidant status (mmol/L) and polyphenols (mmol/L).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Graz, Styria, 8036, Austria
Design:
Monocentric double-blind experiment
Scientific background:
Vitamin B-complex is water-soluble and essential for humans. Vitamin B deficiency is associated with neurologic diseases, heart insufficiency, diminished hormone production and maldigestion. Due to the fact that literature search did not reveal distinct information about natural versus synthetic Vitamin B-complexes this study was initiated to investigate bioavailability and long-term effects of natural Vitamin B-complexes in comparison to synthetic Vitamin B-complexes.
Vitamin B complex was filled in hydroxypropylmethylcellulose capsules (size 0, ivory-coloured). Daily dose = 3 capsules in the morning with 250ml water.
Blinding/Randomization:
The person in charge for manufacturing and blinding arranged an identical packaging of both verum as well as synthetic Vitamin B-complex. Each package consists of 126 capsules per subject and period. Each product was tagged with the subject-number and period (period I and period II).
Study-subjects were blinded by the person in charge for randomization through a sealed envelope. The allocation was in the relation of 1:1 between group A (verum in period I and synthetic Vitamin B-complex in period II) and group B (synthetic Vitamin B-complex in period I and verum in period II). The ultimate subject list was forwarded to the person in charge for randomization after the run-in phase.
Method:
Blood sampling:
Blood (max. 20ml) was collected in a seated position from an antecubital vein.
Time schedule:
Run-in-phase: 3 weeks (no supplementation) Determination of inclusion criteria, nutrition advice, randomization.
Phase I: 6 weeks (supplementation) Group A - natural Vitamin B-complex supplementation every day Group B - synthetic Vitamin B-complex supplementation every day
Blood sampling:
First day:
Fasting value (basic) - Vitamin B-complex supplementation - After 1.5 hours After 4 hours After 7 hours
End of first supplementation:
After 6 weeks
Wash-out period: 2 weeks (without supplementation)
Phase II: 6 weeks (supplementation) Group A - synthetic Vitamin B-complex supplementation every day Group B - natural Vitamin B-complex supplementation every day
Blood sampling:
First day:
Fasting value (basic) - Vitamin B-complex supplementation - After 1.5 hours After 4 hours After 7 hours
End of second supplementation:
After 6 weeks
Wash-out period II: 6 weeks (without supplementation) Final exam - last blood sampling
Drop-out-criteria:
Drawback Compliance (<80% of Vitamin B-complexes) Supplementation of Vitamin B-complexes during run-in-phase or wash-out periods
Primary-target parameters:
Serum concentrations for vitamins B1, B2, B6, B9 and B12
Secondary-target biomarkers:
Serum concentrations for Total antioxidants, total peroxides, peroxidase-activity, polyphenols and homocysteine.
Biometry:
Comparison of interventions in a cross-over approach descriptive and exploratory.
Group comparison: Parametric and non-parametric cross-over comparison Gaussian distribution - (Kolmogorov-Smirnov-test with Lilliefors-significances, alpha =10%).
Effect size: Two-sided 95%-confidence intervals
Analysis:
Intent-to-treat-analysis Per-protocol-analysis Full analysis set
Vitamin B and Homocysteine analysis was done in a routine laboratory. Antioxidants (TAC), peroxidase-activity (EPA), peroxides (TOC) and polyphenols (PPm) were measured by the use of commercially available microtitre assays at a wavelength of 450 vs. 620 nm. In case of PPm a wavelength of 766nm was used.
Implausible values will be scored as missing values. Missing values are not substituted.
Presentation of results:
Minimum-Median-Quartiles-Maximum-Mean-Standard deviation. Box Plots, Bar graph, tables.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) - Synthetic Vitamin B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Synthetic Vitamin B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85µg) - Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Time frame: 20 weeks
Serum Thiamine in microgram per liter Minimum: 36 Maximum: 98
Time frame: 20 weeks
Serum Riboflavin in microgram per liter Minimum: 190 Maximum: 341
Time frame: 20 weeks
Serum Pyridoxine in microgram per liter Minimum: 3.8 Maximum: 161.8
Time frame: 20 weeks
Serum Folic acid in nanogram per liter Minimum: 2.20 Maximum: 58.10
Time frame: 20 weeks
Serum Cobalamin in picogram per liter Minimum: 159 Maximum: 1230
Time frame: 20 weeks
Serum Total peroxides in micromol per liter Minimum: 23 Maximum: 443
Time frame: 20 weeks
Serum total antioxidant capacity in millimole per liter Minimum: 0.31 Maximum: 2.45
Time frame: 20 weeks
Serum endogenous peroxidase-activity in milliunits per milliliter Minimum: 0.79 Maximum: 9.87
Time frame: 20 weeks
Serum Polyphenols in millimole per liter Minimum: 7.45 Maximum: 10.91
Time frame: 20 weeks
Total Homocysteine in Micromole Minimum: 4.00 Maximum: 40.40
Medical University of Graz
Other
Pilot Study for the Evaluation of the Effectiveness of Natural Versus Synthetic Vitamin B Complexes in Humans.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06869018
Diabetes Mellitus, Diabetes Mellitus, Type 2
Fukuoka, Japan
View Trial DetailsNCT05439590
Glucose Metabolism Disorders, Healthy
Bozeman, Montana, United States
View Trial DetailsNCT02585427
Body Weight, Diabetes Mellitus
Singapore
View Trial DetailsNCT02208284
Dyslipidemias, Healthy
New Haven, Connecticut, United States
View Trial Details